Article Details

Strides Pharma debuts with stellar ESG rating of 76/100 in S&P Global CSA 2024

Retrieved on: 2025-01-26 04:30:25

Tags for this article:

Click the tags to see associated articles and topics

Strides Pharma debuts with stellar ESG rating of 76/100 in S&P Global CSA 2024. View article details on hiswai:

Excerpt

Bangalore: Strides Pharma Science Limited has announced that the Company has received an ESG score of 76/100 and CSA score of 75/100 in the ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up